Clinical trial AL-TNBC-01 - TENACITY
A Phase 2, Multicenter, Open-label, Single arm Study of AL101 Monotherapy in Patients with Notch Activated Triple Negative Breast Cancer
Cancers | |
---|---|
Organ | Breast |
Trial status | Trial closed |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 2 |
Academic trial | Non |
Sponsor | Ayala Pharmaceuticals, Inc. |
EudraCT Identifier | 2020-001979-33 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04461600 |
Last update |